Literature DB >> 33425076

Bacterial Profile and Antibiotic Susceptibility Pattern of Urinary Tract Infection among Pregnant Women Attending Antenatal Care at a Tertiary Care Hospital in Southern Ethiopia.

Ashenafi Tula1, Abraham Mikru1, Tsegaye Alemayehu2, Beyene Dobo1.   

Abstract

BACKGROUND: Urinary tract infection is one of the most common bacterial infections encountered in pregnant women with significant morbidity. This study aimed to determine the bacterial profile and its antimicrobial susceptibility pattern of urinary tract infection among pregnant women attending antenatal care (ANC) at a Hawassa University Comprehensive Specialized Hospital (HUCSH), Southern Ethiopia.
METHOD: A cross-sectional study was conducted in which consecutive pregnant women enrolled in the study from March to June 2019. The structured questionnaire used to collect sociodemographic and clinical data in a face-to-face interview. Midstream urine was collected from pregnant women using sterile containers. Culture and sensitivity were performed using a standard operating procedure of the microbiology laboratory. Data entry and analysis were conducted using the statistical package for social sciences (SPSS) version 20. Descriptive and logistic regression was used to conduct the output of the data. The odds ratio at 95% confidence interval was considered as a statistically significant association with a p value <0.05. RESULT: The overall magnitude of urinary tract infection in this study was 7.8% (4.7-10.8%). Escherichia coli was found to be the most frequently isolated (47.8%), followed by Klebsiella pneumoniae (17.4%), Staphylococcus aureus (8.7%), Klebsiella ozaenae, Klebsiella rhinoscleromatis, Citrobacter spp., Salmonella group A, Staphylococcus saprophyticus, and Enterobacter cloacae each (4.3%). Gram-negative bacteria were sensitive to 78.3%, 91.3%, and 100% of ciprofloxacin, gentamicin, and nitrofurantoin, respectively. Gram-positive bacteria were sensitive to clindamycin (100%), gentamicin (100%), and nitrofurantoin (100%) and fully resistant to ceftriaxone (100%) and cefuroxime (100%). There is no statistically significant association (p < 0.05) between the risk factor of urinary tract infection and UTI.
CONCLUSION: The overall prevalence of urinary tract infection among pregnant women attending antenatal care was 7.8%. Escherichia coli were the dominant isolate followed by Klebsiella pneumoniae. Gram-negative isolates are highly sensitive to ciprofloxacin, gentamicin, nitrofurantoin, and ceftriaxone and Gram-positive isolates to gentamicin, clindamycin, and nitrofurantoin. Most of the bacteria are resistant to cotrimoxazole and cefuroxime. There is no statistically significantly associated variable. Screening for the presence of urinary tract infection during pregnancy will improve the quality of antenatal care further reducing complication. The above antibiotics can be prescribed based on the side effect to pregnant women in case empirical treatment is mandatory in the study area.
Copyright © 2020 Ashenafi Tula et al.

Entities:  

Year:  2020        PMID: 33425076      PMCID: PMC7775162          DOI: 10.1155/2020/5321276

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  27 in total

1.  Incidence of urinary tract infection during pregnancy.

Authors:  M A Sheikh; M S Khan; A Khatoon; G M Arain
Journal:  East Mediterr Health J       Date:  2000 Mar-May       Impact factor: 1.628

2.  Prevalence of asymptomatic bacteriuria and its consequences in pregnancy in a rural community of Bangladesh.

Authors:  M Anayet Ullah; A Barman; M A Siddique; A K M E Haque
Journal:  Bangladesh Med Res Counc Bull       Date:  2007-08

Review 3.  Urinary tract infections during pregnancy.

Authors:  J E Delzell; M L Lefevre
Journal:  Am Fam Physician       Date:  2000-02-01       Impact factor: 3.292

4.  Pridominant isolates of urinary tract pathogens and their antimicrobial susceptiblity patterns in Gondar University Teaching Hospital, nothwest Ethiopia.

Authors:  Belay Tessema; Afework Kassu; Andargachew Mulu; Gizachew Yismaw
Journal:  Ethiop Med J       Date:  2007-01

5.  Asymptomatic bacteriuria among pregnant women referred to outpatient clinics in Sanandaj, Iran.

Authors:  Kalantar Enayat; Farhadifar Fariba; Nikkho Bahram
Journal:  Int Braz J Urol       Date:  2008 Nov-Dec       Impact factor: 1.541

6.  Should asymptomatic bacteriuria be screened in pregnancy?

Authors:  Y Uncu; G Uncu; A Esmer; N Bilgel
Journal:  Clin Exp Obstet Gynecol       Date:  2002       Impact factor: 0.146

7.  Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at University of Gondar Teaching Hospital, Northwest Ethiopia.

Authors:  Agersew Alemu; Feleke Moges; Yitayal Shiferaw; Ketema Tafess; Afework Kassu; Belay Anagaw; Abebe Agegn
Journal:  BMC Res Notes       Date:  2012-04-25

8.  Epidemiology of urinary tract infections and antibiotics sensitivity among pregnant women at Khartoum North Hospital.

Authors:  Hamdan Z Hamdan; Abdel Haliem M Ziad; Salah K Ali; Ishag Adam
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-01-18       Impact factor: 3.944

9.  Asymptomatic bacteriuria among pregnant women.

Authors:  Paul Erhunmwunse Imade; Patience Emiolu Izekor; Nosakhare Odeh Eghafona; Onaiwu Idahosa Enabulele; Endurance Ophori
Journal:  N Am J Med Sci       Date:  2010-06

10.  Bacterial profile of urinary tract infection and antimicrobial susceptibility pattern among pregnant women attending at Antenatal Clinic in Dil Chora Referral Hospital, Dire Dawa, Eastern Ethiopia.

Authors:  Behailu Derese; Haji Kedir; Zelalem Teklemariam; Fitsum Weldegebreal; Senthilkumar Balakrishnan
Journal:  Ther Clin Risk Manag       Date:  2016-02-18       Impact factor: 2.423

View more
  1 in total

Review 1.  Bacterial profile and antimicrobial resistance patterns of common bacteria among pregnant women with bacteriuria in Ethiopia: a systematic review and meta-analysis.

Authors:  Legese Chelkeba; Korinan Fanta; Temesgen Mulugeta; Tsegaye Melaku
Journal:  Arch Gynecol Obstet       Date:  2022-01-15       Impact factor: 2.493

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.